Building and financing a drug discovery platform company.
Within two months of creating Catabasis Pharmaceuticals, the company's two founders had developed an innovative approach to drug discovery and development.
Catabasis wanted to build a portfolio of new medicines for their focus area.
Catabasis had initially funded the company through a round of convertible debt but needed a financing plan, an infrastructure and systems to move forward.
TechCXO provided overall strategic direction as well as finance and operations systems -- everything from cash management to budgeting and forecasting to advising on organizational and employee needs.
TechCXO helped to hire the company’s full-time in 2013 and has continued to provide financial leadership through the recent IPO.
Catabasis raised several rounds of equity financing to fund its development and expansion. TechCXO helped to develop the company’s financial and operational capabilities. Catabasis had its initial public offering in June 2015 (CATB) and now has two Ph2 assets in the clinic as well as a robust portfolio of investigational new medicines for the treatment of various disease indications.
"TechCXO has led finance and key operational functions from our founding, through early capital raises, to our IPO."
Jill Milne, Founder & CEO